Digirad (NASDAQ:DRAD) posted its earnings results on Tuesday. The medical equipment provider reported $0.04 earnings per share for the quarter, Morningstar.com reports. The company had revenue of $25.80 million during the quarter. Digirad had a negative net margin of 4.90% and a negative return on equity of 9.16%. Digirad updated its FY 2019 guidance to EPS.
DRAD traded down $0.13 during trading on Wednesday, hitting $4.86. 3,458 shares of the company traded hands, compared to its average volume of 6,568. The stock has a 50-day moving average price of $6.02. Digirad has a 1 year low of $4.20 and a 1 year high of $19.50. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.18 and a current ratio of 1.59.
Separately, ValuEngine cut shares of Digirad from a “buy” rating to a “hold” rating in a research note on Tuesday, July 2nd.
Digirad Company Profile
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services.
Featured Article: What is a Special Dividend?
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.